BRAINSTORM CELL THERAPEUTICS INC. Other Non-Current Assets
BRAINSTORM CELL THERAPEUTICS INC. (BCLI) had Other Non-Current Assets of $25.00 thousand as of 2025-12-31, per its 10-K filed 2026-03-31.
Financial Statements › Balance Sheet › Assets › Assets, Noncurrent
us-gaap:OtherAssetsNoncurrent · last filed 2026-03-31
- 2025-12-31: Other Assets, Noncurrent $25.00K.
- 2025-09-30: Other Assets, Noncurrent $872.00K.
- 2025-06-30: Other Assets, Noncurrent $1.05M.
- 2025-03-31: Other Assets, Noncurrent $1.24M.
| Period end | Other Assets, Noncurrent | Other Assets, Noncurrent as first filed |
|---|---|---|
| 2025-12-31 | $25.00K 10-K · filed 2026-03-31 | |
| 2025-09-30 | $872.00K 10-Q · filed 2025-11-14 | |
| 2025-06-30 | $1.05M 10-Q · filed 2025-08-14 | |
| 2025-03-31 | $1.24M 10-Q · filed 2025-05-15 | |
| 2024-12-31 | $22.00K 10-K · filed 2026-03-31 | $1.45M 10-K · filed 2025-03-31 |
| 2024-09-30 | $1.66M 10-Q · filed 2024-11-14 | |
| 2024-06-30 | $1.87M 10-Q · filed 2024-08-14 | |
| 2024-03-31 | $2.09M 10-Q · filed 2024-05-14 | |
| 2023-12-31 | $2.31M 10-K · filed 2025-03-31 | |
| 2023-09-30 | $4.14M 10-Q · filed 2023-11-14 | |
| 2023-06-30 | $4.53M 10-Q · filed 2023-08-14 | |
| 2023-03-31 | $4.94M 10-Q · filed 2023-05-15 | |
| 2022-12-31 | $5.34M 10-K · filed 2024-04-01 | |
| 2022-09-30 | $5.75M 10-Q · filed 2022-11-14 | |
| 2022-06-30 | $6.16M 10-Q · filed 2022-08-15 | |
| 2022-03-31 | $6.53M 10-Q · filed 2022-05-16 | |
| 2021-12-31 | $6.00M 10-K · filed 2023-03-30 | |
| 2021-09-30 | $6.59M 10-Q · filed 2021-11-15 | |
| 2021-06-30 | $7.05M 10-Q · filed 2021-08-05 | |
| 2021-03-31 | $7.54M 10-Q · filed 2021-04-26 | |
| 2020-12-31 | $8.02M 10-K · filed 2022-03-28 | |
| 2020-09-30 | $2.35M 10-Q · filed 2020-10-15 | |
| 2020-06-30 | $2.59M 10-Q · filed 2020-08-05 | |
| 2020-03-31 | $2.87M 10-Q · filed 2020-05-07 | |
| 2019-12-31 | $3.17M 10-K · filed 2021-02-04 | |
| 2019-09-30 | $3.14M 10-Q · filed 2019-11-14 | |
| 2019-06-30 | $3.33M 10-Q · filed 2019-08-13 | |
| 2019-03-31 | $3.59M 10-Q · filed 2019-05-10 | |
| 2018-12-31 | $958.00K 10-K · filed 2020-02-18 | |
| 2018-09-30 | $1.15M 10-Q · filed 2018-10-29 | |
| 2018-06-30 | $1.46M 10-Q · filed 2018-07-23 | |
| 2018-03-31 | $1.55M 10-Q · filed 2018-05-14 | |
| 2017-12-31 | $1.80M 10-K · filed 2019-04-01 | |
| 2017-09-30 | $384.00K 10-Q · filed 2017-10-17 | |
| 2017-06-30 | $319.00K 10-Q · filed 2017-08-14 | |
| 2017-03-31 | $307.00K 10-Q · filed 2017-05-15 | |
| 2016-12-31 | $322.00K 10-K · filed 2018-03-08 | |
| 2016-09-30 | $337.00K 10-Q · filed 2016-11-14 | |
| 2016-06-30 | $341.00K 10-Q · filed 2016-08-11 | |
| 2016-03-31 | $304.00K 10-Q · filed 2016-05-10 | |
| 2015-12-31 | $292.00K 10-K · filed 2017-03-29 | |
| 2014-12-31 | $333.00K 10-K · filed 2016-03-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| INTENSITY THERAPEUTICS, INC. (INTS) | United States | $0.013B | -1.08 |
| Pluri Inc. (PLUR) | $0.014B | ||
| IN8BIO, INC. (INAB) | United States | $0.012B | -0.76 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| Passage BIO, Inc. (PASG) | United States | $0.015B | -0.43 |
| DYADIC INTERNATIONAL INC (DYAI) | United States | $0.016B | |
| BioCardia, Inc. (BCDA) | United States | $0.016B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| Jasper Therapeutics, Inc. (JSPR) | United States | $0.020B | -0.37 |